↓ Skip to main content

High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity

Overview of attention for article published in BMC Complementary Medicine and Therapies, June 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
5 news outlets
twitter
1 X user
wikipedia
1 Wikipedia page
video
2 YouTube creators

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity
Published in
BMC Complementary Medicine and Therapies, June 2016
DOI 10.1186/s12906-016-1154-5
Pubmed ID
Authors

Jai-Hong Cheng, Chia-Ling Tsai, Yi-Yang Lien, Meng-Shiou Lee, Shyang-Chwen Sheu

Abstract

Hericium erinaceus (HE) is a well-known mushroom in traditional Chinese food and medicine. HE extracts from the fruiting body and mycelia not only exhibit immunomodulatory, antimutagenic and antitumor activity but also have neuroprotective properties. Here, we purified HE polysaccharides (HEPS), composed of two high molecular weight polysaccharides (1.7 × 10(5) Da and 1.1 × 10(5) Da), and evaluated their protective effects on amyloid beta (Aβ)-induced neurotoxicity in rat pheochromocytoma PC12 cells. HEPS were prepared and purified using a 95 % ethanol extraction method. The components of HEPS were analyzed and the molecular weights of the polysaccharides were determined using high-pressure liquid chromatography (HPLC). The neuroprotective effects of the polysaccharides were evaluated through a 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay and an MTT assay and by quantifying reactive oxygen species (ROS) and mitochondrial membrane potentials (MMP) of Aβ-induced neurotoxicity in cells. Our results showed that 250 μg/ml HEPS was harmless and promoted cell viability with 1.2 μM Aβ treatment. We observed that the free radical scavenging rate exceeded 90 % when the concentration of HEPS was higher than 1 mg/mL in cells. The HEPS decreased the production of ROS from 80 to 58 % in a dose-dependent manner. Cell pretreatment with 250 μg/mL HEPS significantly reduced Aβ-induced high MMPs from 74 to 51 % and 94 to 62 % at 24 and 48 h, respectively. Finally, 250 μg/mL of HEPS prevented Aβ-induced cell shrinkage and nuclear degradation of PC12 cells. Our results demonstrate that HEPS exhibit antioxidant and neuroprotective effects on Aβ-induced neurotoxicity in neurons.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 58 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 25%
Researcher 5 8%
Student > Doctoral Student 4 7%
Other 4 7%
Student > Ph. D. Student 4 7%
Other 13 22%
Unknown 14 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 15%
Pharmacology, Toxicology and Pharmaceutical Science 8 14%
Medicine and Dentistry 7 12%
Agricultural and Biological Sciences 5 8%
Immunology and Microbiology 4 7%
Other 11 19%
Unknown 15 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2024.
All research outputs
#903,901
of 25,128,618 outputs
Outputs from BMC Complementary Medicine and Therapies
#129
of 3,932 outputs
Outputs of similar age
#17,126
of 348,699 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#5
of 81 outputs
Altmetric has tracked 25,128,618 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,932 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,699 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.